Abstract
Vaccines formulated with 4 to 10 among 13 tick salivary antigens are validated in cattle and dogs, however, their manufacturing with good cost-benefit is unfeasible due to the large number of their components. Furthermore, some targets are poor immunogens because they contain insufficient T helper cell epitopes (HTLs) and thus provide weak coverage of bovine class II alleles. This project…